Up to 30 % of ovarian cancer and TNBC patients show functional impairment of BRCA1/2 genes [3, 4] and women carrying BRCA1/2 germline mutations are at an increased risk of developing ovarian and breast cancer [5–8]. Here, BRCA1 is linked to ovarian carcinoma.